Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 35.00 | |
5 mg | In stock | $ 57.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 176.00 | |
50 mg | Inquiry | $ 297.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 63.00 |
Description | Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren's syndrome. |
Molecular Weight | 489.55 |
Formula | C20H38Cl2N2O3S2 |
CAS No. | 153504-70-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cevimeline hydrochloride hemihydrate 153504-70-2 Neuroscience AChR SNI 2011 Cevimeline hydrochloride Hemihydrate secretion SNI-2011 dry Quinuclidine Muscarinic acetylcholine receptor SNI2011 muscarinic xerostomia mAChR long-acting Cevimeline Hydrochloride parasympathomimetic AF102B hydrochloride hemihydrate Inhibitor sialogogue inhibit salivation mouth inhibitor